95 related articles for article (PubMed ID: 9599265)
21. Determining incidence of extended spectrum beta-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001-2002.
Bouchillon SK; Johnson BM; Hoban DJ; Johnson JL; Dowzicky MJ; Wu DH; Visalli MA; Bradford PA
Int J Antimicrob Agents; 2004 Aug; 24(2):119-24. PubMed ID: 15288309
[TBL] [Abstract][Full Text] [Related]
22. Synergistic effects of mupirocin and an isoflavanone isolated from Erythrina variegata on growth and recovery of methicillin-resistant Staphylococcus aureus.
Sato M; Tanaka H; Yamaguchi R; Kato K; Etoh H
Int J Antimicrob Agents; 2004 Sep; 24(3):241-6. PubMed ID: 15325427
[TBL] [Abstract][Full Text] [Related]
23. Antibacterial activity of linezolid and vancomycin in an in vitro pharmacodynamic model of gram-positive catheter-related bacteraemia.
Wiederhold NP; Coyle EA; Raad II; Prince RA; Lewis RE
J Antimicrob Chemother; 2005 May; 55(5):792-5. PubMed ID: 15814598
[TBL] [Abstract][Full Text] [Related]
24. Coexistence of vancomycin-resistant enterococci and Staphylococcus aureus in the intestinal tracts of hospitalized patients.
Ray AJ; Pultz NJ; Bhalla A; Aron DC; Donskey CJ
Clin Infect Dis; 2003 Oct; 37(7):875-81. PubMed ID: 13130397
[TBL] [Abstract][Full Text] [Related]
25. Rapid identification of antibacterial agents effective against Staphylococcus aureus using small-molecule macroarrays.
Bowman MD; O'Neill JC; Stringer JR; Blackwell HE
Chem Biol; 2007 Apr; 14(4):351-7. PubMed ID: 17462570
[TBL] [Abstract][Full Text] [Related]
26. Novel tetrahydro-thieno pyridyl oxazolidinone: an antibacterial agent.
Lohray BB; Lohray VB; Srivastava BK; Kapadnis PB; Pandya P
Bioorg Med Chem; 2004 Sep; 12(17):4557-64. PubMed ID: 15358283
[TBL] [Abstract][Full Text] [Related]
27. Structure-activity studies of echinomycin antibiotics against drug-resistant and biofilm-forming Staphylococcus aureus and Enterococcus faecalis.
Socha AM; Laplante KL; Russell DJ; Rowley DC
Bioorg Med Chem Lett; 2009 Mar; 19(5):1504-7. PubMed ID: 19185486
[TBL] [Abstract][Full Text] [Related]
28. A new class of anti-MRSA and anti-VRE agents: preparation and antibacterial activities of indole-containing compounds.
Yamamoto Y; Kurazono M
Bioorg Med Chem Lett; 2007 Mar; 17(6):1626-8. PubMed ID: 17254785
[TBL] [Abstract][Full Text] [Related]
29. In vitro activity of novel rifamycins against gram-positive clinical isolates.
Murphy CK; Karginova E; Sahm D; Rothstein DM
J Antibiot (Tokyo); 2007 Sep; 60(9):572-6. PubMed ID: 17917240
[TBL] [Abstract][Full Text] [Related]
30. [Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections].
Li JT; Li Y; Wang J;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):365-74. PubMed ID: 12820911
[TBL] [Abstract][Full Text] [Related]
31. Antimicrobial protein from Streptomyces fulvissimus inhibitory to methicillin resistant Staphylococcus aureus.
Malik H; Sur B; Singhal N; Bihari V
Indian J Exp Biol; 2008 Apr; 46(4):254-7. PubMed ID: 18512335
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial activity of 2-arylbenzofurans from Morus species against methicillin-resistant Staphylococcus aureus.
Fukai T; Kaitou K; Terada S
Fitoterapia; 2005 Dec; 76(7-8):708-11. PubMed ID: 16236463
[TBL] [Abstract][Full Text] [Related]
33. Investigation into the efficacy of disinfectants against MRSA and vancomycin-resistant enterococci.
Goroncy-Bermes P
Zentralbl Hyg Umweltmed; 1998 Dec; 201(4-5):297-309. PubMed ID: 9916285
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of bis, tris and tetra(dihydrocaffeoyl)polyamine conjugates as antibacterial agents against VRSA.
Yingyongnarongkul BE; Apiratikul N; Aroonrerk N; Suksamrarn A
Arch Pharm Res; 2008 Jun; 31(6):698-704. PubMed ID: 18563350
[TBL] [Abstract][Full Text] [Related]
35. [Study on in vitro and in vivo antibacterial activity of pheromonicin-SA].
Huang Y; Zhang J; Dai P; Qiu XQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):749-52. PubMed ID: 15573744
[TBL] [Abstract][Full Text] [Related]
36. In vitro synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid and vancomycin.
Pankey G; Ashcraft D; Patel N
Antimicrob Agents Chemother; 2005 Dec; 49(12):5166-8. PubMed ID: 16304195
[TBL] [Abstract][Full Text] [Related]
37. N-thiolated 2-oxazolidinones: a new family of antibacterial agents for methicillin-resistant Staphylococcus aureus and Bacillus anthracis.
Mishra RK; Revell KD; Coates CM; Turos E; Dickey S; Lim DV
Bioorg Med Chem Lett; 2006 Apr; 16(8):2081-3. PubMed ID: 16464583
[TBL] [Abstract][Full Text] [Related]
38. Anti-methicillin-resistant Staphylococcus aureus (MRSA) activity of MC21-B, an antibacterial compound produced by the marine bacterium Pseudoalteromonas phenolica O-BC30T.
Isnansetyo A; Kamei Y
Int J Antimicrob Agents; 2009 Aug; 34(2):131-5. PubMed ID: 19329285
[TBL] [Abstract][Full Text] [Related]
39. In vitro antibacterial activity of echinomycin and a novel analogue, YK2000, against vancomycin-resistant enterococci.
Kim JB; Lee GS; Kim YB; Kim SK; Kim YH
Int J Antimicrob Agents; 2004 Dec; 24(6):613-5. PubMed ID: 15555887
[TBL] [Abstract][Full Text] [Related]
40. Three new isoflavanones from Erythrina costaricensis.
Tanaka H; Hattori H; Oh-Uchi T; Sato M; Sako M; Tateishi Y; Rizwani GH
Nat Prod Res; 2009; 23(12):1089-94. PubMed ID: 19662573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
